Key result
MicroRNAs dynamically regulate vascular smooth muscle cell phenotypic switching in vascular disease.
The phenotype of vascular smooth muscle cells (VSMCs) is dynamically regulated in response to various stimuli. In a cellular process known as phenotype switching, VSMCs alternate between a contractile and synthetic phenotype state. Deregulation of phenotype switching is associated with vascular disorders such as atherosclerosis, restenosis after angioplasty, and pulmonary hypertension. An important role for microRNAs (miRNAs) in VSMC development and phenotype switching has recently been uncovered. Individual miRNAs are involved in promoting both contractile and synthetic VSMC phenotype. In this review, we summarize recent advances in the understanding of miRNA function in the regulation of VSMC phenotype regulation.
No takes yet. Share an insight, caveat, or question.
Davis‐Dusenbery et al. (2011) conducted a review in Vascular disorders (atherosclerosis, restenosis, pulmonary hypertension). microRNAs (miRNAs) was evaluated. MicroRNAs play an important role in promoting both contractile and synthetic vascular smooth muscle cell phenotypes and their dynamic switching in vascular disorders.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: